Highlights

Simons Trading Research

Author: simonsg   |   Latest post: Thu, 28 Apr 2022, 10:32 PM

 

DBS Group - Bullseye

Author:   |    Publish date:


  • Robust wealth income will be key in driving double-digit fee income growth in FY21F. A healthy pipeline of loan growth ( ~8% y-o-y) should help bolster NII.
  • Aside from model-led credit cost reductions, DBS has ~S$1bn in management overlays to be written back (timeline dependent on moratorium risks).
  • Reiterate ADD on DBS. The lifting of MAS’s dividend cap is a key re-rating catalyst.

Robust Non-II Growth Trajectory; We Expect ~12% ROE for DBS in FY21F

  • DBS Group (SGX:D05) had all cylinders firing in 1Q21 — robust wealth management income (+50% q-o-q, +29% y-o-y) from strong investor sentiment amid the low rate environment, rising customer treasury activity (treasury income: +101% q-o-q, +12% y-o-y), a strong rebound in loan growth momentum (+4% q-o-q) and an extra S$190m lift from impairment write-backs.
  • A pick-up in regional GDP growth underlines DBS’s confidence in achieving double-digit fee income growth in FY21F (FY20: flattish) and visibility of mid-to-high single-digit loan growth. We think that an improvement of ROE to ~12% in FY21F (FY20: 9%) is justified, given its robust non-II growth trajectory, offsetting NII weakness.

Impairment Write-back Bullet of ~S$1bn to Come

  • DBS’s impairment write-back was a key positive surprise factor in 1Q21’s net profit beat. This came entirely from asset quality improvements feeding into its ECL model, stemming from a rise in repayments (e.g. from better business cashflows, having raised funds in the bond markets) or an upgrade of customer risk ratings.
  • FY20 pre-emptive impairments ~S$1.3bn in management overlays — to account for provisioning risks owing to loan moratoriums declared last year — an additional amount yet to be released from DBS’s buffers. Taking into account capital needs (as general provisions feed into Tier-2 capital calculations), ~S$1bn of this could be written back when residual risks from the moratoriums taper off — we believe this to be an earnings boost to come.

DBS Is Still on the Look-out for Meaningful Acquisitions

  • Operating metrics of Shenzhen Rural Commercial Bank (SZRCB) are encouraging the sale of Citi’s consumer businesses, DBS views its Citigold and credit card franchises to be a good fit. Of the 13 markets up for sale, we think India, Indonesia, and Taiwan offer the best value to DBS, given its geographical exposure. A meaningful acquisition could improve capital efficiency to ~12.5-13.5%.

Reiterate ADD, With GGM-based Target Price of S$32.64

  • We raise our DBS's FY21-23F earnings per share forecast by quality metrics (lower NPA formation, rising repayments) make a case for lowering our credit costs estimates to ~16bp (from ~26bp) in FY21F (we assumed steady-state-specific provisions).
  • Although DBS trades at a premium to peers at 1.4x FY21F P/BV, we see more value enhancement going forward as its revenue drivers scale new highs.

Takeaways From DBS's 1Q21 Results Briefing

  • DBS recorded a loan growth of 4% q-o-q in 1Q21. At DBS’s results briefing, management said growth was broad-based —
    • ~S$3bn for a liquidity drawdown,
    • ~S$2bn in trade finance (mostly commodity and manufacturing),
    • ~S$1bn in housing loans, and
    • the rest were non-trade corporate loans and loans related to the wealth management segment.
  • To this end, DBS had revised its loans in Hong Kong (mostly large corporates) remain under extended moratorium terms. The S$190m in GP writeback in 1Q21 came from better repayment trends and risk upgrades feeding into its ECL model.
  • Apart from more ECL-model-related writebacks, DBS had ~S$1.3bn in management overlays that were previously set aside as pre-emptive impairment buffers in FY20. Realistically, this presents an opportunity to release ~S$1bn in impairments in time to come (taking into account tier-2 capital needs) — providing an earnings boost when this happens.
  • Operating metrics of Shenzhen Rural Commercial Bank (SZRCB) are encouraging, with steady profitability (+11% CAGR in FY15-20), contained asset quality (NPL: 1.1%) and strong 14.4% CAR. The value of this acquisition lies in the potential to deepen DBS’s Greater Bay area strategy by levering on DBS’s digital capabilities to tap SCRZB’s local network.
  • Meanwhile, the integration of Lakshmi Vilas Bank has advanced DBS India’s growth of gold-backed loans and lowered its deposit costs. Legacy NPAs have also reduced.

Re-rating Catalysts and Downside Risks

  • Re-rating catalysts are a lifting of the MAS’s dividend cap on banks and a rise in Fed rates.
  • Downside risks are a new wave of COVID-19-related lockdowns, leading to movement restriction orders and, consequently, reduced business volumes and asset quality deterioration.

Source: CGS-CIMB Research - 30 Apr 2021

Share this
Labels: DBS

Related Stocks

Chart Stock Name Last Change Volume 
DBS 31.20 +0.16 (0.52%) 5,215,100 

  Be the first to like this.
 


TOP ARTICLES

1. Thai Beverage - Sustainable Recovery Outlook; Stay BUY RHB Investment Research Reports
2. Fu Yu Corp - Supply Chain Business Pulling Its Weight RHB Investment Research Reports
3. EC World REIT - in Rough Seas RHB Investment Research Reports
4. CLI Leads Buyback Tally, Wee Investments Ups UOL Stake SGX Market Updates
5. First Resources - Decent Start to the Year RHB Investment Research Reports
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

199  204  223  555 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 Sembcorp Marine 0.098+0.002 
 HSI 18200MBeP.. 0.058+0.001 
 YZJ Shipbldg SGD 0.88+0.055 
 ThaiBev 0.695+0.005 
 Oceanus^ 0.0170.00 
 HSI 19400MBeP.. 0.031+0.011 
 YZJ Fin Hldg 0.41-0.005 
 HSI 21400MBeC.. 0.089-0.007 
 Jiutian Chemical 0.103-0.001 
 HSI 20400MBeC.. 0.152-0.007 
PARTNERS & BROKERS